Obesitat i Diabetis Tipus 2: Biologia del Teixit Adipós

David Sánchez-Infantes

David Sánchez-Infantes is a Miguel Servet Investigator Funded by the Instituto Carlos III (National Institute of Health of Spain). He is an emerging principal investigator and his team focusses on the study of obesity and type 2 diabetes. They search for molecules secreted by white and brown adipose tissue involved in the inflammatory state that occurs during the obesity. They also evaluate the capability of these molecules to inhibit/activate the brown adipose tissue and to modulate the properties of subcutaneous white adipose tissue, which is replaced by thermogenic beige adipose tissue (browning) in obesity. The goal of this group is to decipher why the excess of fat is inhibiting the normal activation and function of brown adipose tissue and browning, and to search for novel pharmacological approaches to treat obesity and related diseases.

Publications as Sanchez-Infantes, D

Publications as Sanchez, D

Líneas de investigación

Novel cytokines involved in the inhibition/activation of brown adipose tissue function and browning

We search for molecules secreted by white and/or brown adipose tissue involved in the inflammatory state that occurs during obesity. We also evaluate the capability of these molecules to inhibit/activate brown adipose tissue, and to modulate the properties of subcutaneous white adipose tissue, which is replaced by thermogenic beige adipose tissue (browning) in obesity. The goal of this group is to decipher why the excess of fat  inhibits the normal activation and function of brown adipose tissue and browning, and to search for novel pharmacological approaches to treat obesity and related diseases.

Research projects

ONGOING PROJECTS

Miguel Servet contract
Code: MSI15/00106
Principal Investigator David Sanchez-Infantes
Start Date: 01/01/2016
End Date: 31/12/2020

Function of cells of the immune system present in human adipose tissue in the development of Diabetes type 2: Oncostatin m and other potential therapeutic targets
Code: PI17/01455
Principal Investigator David Sanchez-Infantes
Start Date: 01/01/2018
End Date: 31/12/2020

Projecte vinculat al contracte Miquel Servet:  Implication of oncostatin m and interleukin 33 in the metabolic benefits after bariatric surgery: dual anti-obesity strategy
Code: CP15/00106
Investigator principal: David Sanchez-Infantes
Fecha inicio: 01/01/2016
Fecha final: 31/12/2018

Group Members

David Sánchez-Infantes, dsanchez(ELIMINAR)@igtp.cat, Principal Investigator
Irene Piquer, ipiquer(ELIMINAR)@igtp.cat, PhD Student

Més informació

Contacte

David Sánchez-Infantes

(+34) 93 557 2832

dsanchez(ELIMINAR)@igtp.cat